NCT07145255
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07145255
Title Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MBrace Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
START, Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
START, Astera RECRUITING East Brunswick New Jersey 08816 United States Details
NEXT, Dallas RECRUITING Irving Texas 75039 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
START, Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT, Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field